Bio-Rad Laboratories, Inc.
BIO
$265.26
$0.940.36%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 317.80M | 64.00M | -715.80M | 653.17M | -2.17B |
| Total Depreciation and Amortization | 40.60M | 38.10M | 39.20M | 38.90M | 36.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -319.00M | -15.80M | 1.02B | -749.21M | 2.91B |
| Change in Net Operating Assets | 77.10M | 43.60M | -216.00M | 220.70M | -679.50M |
| Cash from Operations | 116.50M | 129.90M | 124.20M | 163.56M | 97.60M |
| Capital Expenditure | -45.70M | -34.40M | -42.91M | -40.23M | -42.30M |
| Sale of Property, Plant, and Equipment | 100.00K | -- | -49.00K | 57.00K | 100.00K |
| Cash Acquisitions | -216.70M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 146.90M | 37.30M | 12.42M | -15.46M | 11.30M |
| Cash from Investing | -115.40M | 2.90M | -30.54M | -55.64M | -30.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00K | -100.00K | -41.00K | -123.00K | -100.00K |
| Issuance of Common Stock | 4.20M | 4.30M | 3.91M | 5.10M | 4.70M |
| Repurchase of Common Stock | -140.30M | -101.90M | -134.00K | -100.97M | -101.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -29.98M | 0.00 | 0.00 |
| Cash from Financing | -136.30M | -97.70M | -26.25M | -95.99M | -96.60M |
| Foreign Exchange rate Adjustments | -16.20M | -1.80M | 10.22M | -7.52M | 3.80M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -48.00K | 48.00K | -- |
| Net Change in Cash | -151.40M | 33.30M | 77.58M | 4.47M | -26.10M |